- Lobbying
- Anna AND Bartlett
Lobbying Arrangements Results for 'Anna Bartlett'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues pertaining to chronic kidney disease, generally; and issues specifically relating to end-stage renal disease (ESRD) drugs, innovation, and reimbursement (including Medicare coverage and reim... |
Akebia Therapeutics Inc
|
Chamber Hill Strategies | |||
Details Issues related to hearing health and hearing restoration. |
Frequency Therapeutics Inc.
|
Chamber Hill Strategies | |||
Details Policies impacting hospitals and health systems |
Logan Health (formally known as Kalispell Regional Healthcare)
|
Chamber Hill Strategies | |||
Details Issues related to hospital area wage index; policies that affect hospitals in P.L. 116-123, the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020; P.L. 116-127, the Famili... |
Health and Hospitals, Inc.
|
Chamber Hill Strategies | |||
Details General education around paid family, medical and sick leave issues; paid sick day policies in P.L. 117-2, the Consolidated Appropriations Act, 2021, H.R. 804/S. 248, the FAMILY Act; policies conta... |
National Partnership for Women and Families
|
Chamber Hill Strategies | |||
Details Policies affecting hospitals and health systems |
Covenant HealthCare
|
Chamber Hill Strategies | |||
Details Funding for the Military Burn Research Program Prevention of burns and injury related to home oxygen therapy |
American Burn Association
|
Chamber Hill Strategies | |||
Details H.R.1839, Medicaid Services and Accountability Act of 2019; Education and issues related to Medicaid; issues related to Medicare Advantage STARS quality program and Medicare Part D; S.1895, Lower H... |
WellCare Health Plans, Inc.
|
Chamber Hill Strategies | |||
Details Policies related to third party payments; proposals related to integrate care for ESRD beneficiaries. |
U.S. Renal Care
|
Chamber Hill Strategies | |||
Details FY24 Appropriations maintaining telehealth regulations and flexibilities beyond public health emergency HR 2584 - SAVE Act HR 3561 - PATIENT Act HR 1613 - Drug Price Transparency in Medicaid Act HR... |
Indiana University Health, Inc.
|
Mrs. DEBORAH HOHLT | |||
Details Policies to address health disparities in kidney disease, patient literacy, diversity in clinical trial participation, FDA/CMS communications, and Medicare payment modernization, generally, and rel... |
Saghmos Therapeutics, Inc.
|
Chamber Hill Strategies | |||
Details CHIPS+ Science Act legislation related to amateur student-athletics, name, image, likeness supporting Ukrainian students and faculty to come and study in the U.S. Provisions related to FY24 appropr... |
THE TRUSTEES OF PURDUE UNIVERSITY
|
Mrs. DEBORAH HOHLT | |||
Details Policies that affect hospitals, skilled nursing facilities, and health systems, including proposed regulations to establish nurse staffing ratios in skilled nursing facilities. Policies affecting e... |
Sanford Health
|
Chamber Hill Strategies | |||
Details General education around long term services and supports, home and community-based services issues, spousal impoverishment, Medicaid eligibility in Section 1115 waivers, Money Follows the Person pr... |
National Academy of Elder Law Attorneys, Inc.
|
Chamber Hill Strategies | |||
Details Issues pertaining to access to, coverage of and reimbursement for dialysis services and kidney care, including integrated and coordinated care, including but not limited to H.R. 8254/S. 4574, the B... |
American Renal Associates
|
Chamber Hill Strategies | |||
Details Issues pertaining to physician payment and quality measurement, including HR 2474, Strengthening Medicare for Patients and Providers Act; observation care, including HR 5138, Improving Access to Me... |
Society of Hospital Medicine
|
Chamber Hill Strategies | |||
Details Issues generally related to biopharmaceutical drugs and drug development programs, including, but not limited to: Orphan Drug Act incentives, including H.R. 1629/S.250, the Fairness in Orphan Drug ... |
BioMarin Pharmaceutical Inc.
|
Chamber Hill Strategies | |||
Details Issues related to paid family medical leave and disability insurance. Issues related to requirements for the application of the Employee Retirement Income Security Act of 1974 (ERISA) to general ac... |
New York Life Insurance Company
|
in-house lobbying | |||
Details LEGISLATIVE House H.R. 2798- CFPB Transparency and Accountability Reform Act H.R. 1410- Consumer Financial Protection Commission Act H.R. 1382- TABS Act of 2023 H.R. 1313- Transparency in CFPB Cos... |
CONSUMER BANKERS ASSOCIATION
|
in-house lobbying | |||
Details AD&C Lending, FHA Reform, Affordable Housing Reform, GSE Reform, Corporate Transparency Act of 2019, Violence Against Women Act, Dodd-Frank Reform Interior and Environment Appropriations, Energy an... |
National Association of Home Builders
|
in-house lobbying | |||
Details H.R. 2670/S. 2226, National Defense Authorization Act for Fiscal Year 2024 H.R. 6131, Commercial Space Act of 2023 Draft legislation regarding Department of Commerce Office of Space Commerce missi... |
Chamber of Commerce of the U.S.A.
|
in-house lobbying |